Department of Pharmacology, School of Pharmaceutical Sciences, Universiti Sains Malaysia, 11800 Penang, Malaysia.
BMC Complement Altern Med. 2014 Jul 4;14:220. doi: 10.1186/1472-6882-14-220.
Recently, there has been increasing interest in Ficus deltoidea Jack. (Moraceae) due to its chemical composition and the potential health benefits. The present study was undertaken to investigate the effect of extracts of F. deltoidea leaves on diabetes.
The petroleum ether, chloroform and methanol extracts of F. deltoidea were prepared and subjected to standardization using preliminary phytochemical and HPLC analysis. Dose selection was made on the basis of acute oral toxicity study (50-5000 mg/kg b. w.) as per OECD guidelines. Diabetes mellitus was induced with streptozotocin and rats found diabetic were orally administered with the extract (250, 500 and 1000 mg/kg) for 14 days. Levels of blood glucose and insulin were measured in control as well as diabetic rats on 0, 7 and 14th day. In addition, glucose metabolism regulating gene expression was assessed using RT-PCR.
HPLC analysis revealed that the methanol extract is enriched with C-glycosylflavones particularly, vitexin and isovitexin. In oral glucose tolerance test, oral administration of the methanol extract increased the glucose tolerance. The methanol extract showed significant (P < 0.01) antidiabetic activity. The extract treatment caused significant reduction (p < 0.01) in elevated fasting blood glucose level in streptozotocin-induced diabetic rats. The streptozotocin-related weight loss in rats was noticeably reversed by the extract treatment. Finally, RT-PCR analysis revealed a novel mechanisms for the anti-diabetic action of methanol extract of F. deltoidea. The extract exerted its effect via an increase of insulin secretion which impeded the hepatic glucose production, via down-regulation of phosphoenolpyruvate carboxykinase and glucose-6-phosphatase genes expression on one hand, and up-regulation of hepatic GK and PPARγ genes expression on the other hand. The extract caused an increased expression of GLUT-4 gene expression in skeletal muscles which leads to normalize the hyperglycemia. The extract also nullified the toxic effects of streptozitocin by blocking its entry into the islet β-cells through reducing the expression of GLUT-2 gene.
It can be concluded that, F. deltoidea could potentially inhibits the streptozitocin-induced hyperglycemia in rats. Further the herb can be utilized as useful remedy for alleviation of diabetes complications.
由于其化学成分和潜在的健康益处,三叶榕(桑科)越来越受到关注。本研究旨在探讨三叶榕叶提取物对糖尿病的影响。
制备三叶榕叶的石油醚、氯仿和甲醇提取物,并通过初步的植物化学和 HPLC 分析进行标准化。根据 OECD 指南,基于急性口服毒性研究(50-5000mg/kg b.w.)选择剂量。用链脲佐菌素诱导糖尿病,糖尿病大鼠经口给予提取物(250、500 和 1000mg/kg)14 天。在第 0、7 和 14 天测量对照和糖尿病大鼠的血糖和胰岛素水平。此外,使用 RT-PCR 评估葡萄糖代谢调节基因表达。
HPLC 分析表明,甲醇提取物富含 C-糖基黄酮类化合物,特别是牡荆素和异牡荆素。在口服葡萄糖耐量试验中,口服给予甲醇提取物可提高葡萄糖耐量。甲醇提取物表现出显著的(P<0.01)抗糖尿病活性。提取物处理可显著降低(p<0.01)链脲佐菌素诱导的糖尿病大鼠的空腹血糖升高。提取物处理明显逆转了链脲佐菌素引起的大鼠体重减轻。最后,RT-PCR 分析揭示了三叶榕甲醇提取物抗糖尿病作用的新机制。提取物通过增加胰岛素分泌来发挥作用,一方面通过下调磷酸烯醇丙酮酸羧激酶和葡萄糖-6-磷酸酶基因表达,另一方面通过上调肝 GK 和 PPARγ 基因表达来阻止肝葡萄糖产生,从而发挥作用。提取物导致骨骼肌中 GLUT-4 基因表达增加,使高血糖正常化。提取物还通过减少 GLUT-2 基因的表达来阻止链脲佐菌素进入胰岛β细胞,从而消除了链脲佐菌素的毒性作用。
可以得出结论,三叶榕可能抑制链脲佐菌素诱导的大鼠高血糖。此外,该草药可作为缓解糖尿病并发症的有用药物。